ANN INTERN MED:研究显示三分之一HIV患者未接种乙肝疫苗!

2017-12-26 佚名 Medicalxpress

尽管感染风险高,美国超过三分之一的艾滋病病毒感染者未能接种乙型肝炎疫苗。这些发现发表在“内科学年鉴”上。

尽管感染风险高,美国超过三分之一的艾滋病病毒感染者未能接种乙型肝炎疫苗。这些发现发表在“内科学年鉴”上。


艾滋病病毒感染者乙肝病毒感染的风险增加,建议接种疫苗。然而,以乙型肝炎为主的艾滋病病毒感染者与肝脏有关的死亡人数占与艾滋病无关的死亡人数最多。 2016年,世界卫生组织(WHO)决定到2030年消除HBV感染作为公共卫生威胁。


为了评估艾滋病病毒感染者接种乙肝疫苗的情况,并为世界卫生组织设立基准,美国疾病控制和预防中心(CDC)的研究人员调查了全国有代表性的18089名接受艾滋病医疗的成年人,他们参加了医疗监测他们发现超过三分之一的美国艾滋病病毒感染者没有接种过乙型肝炎疫苗。此外,在接受艾滋病毒护理的1年期间,只有十分之一的接种候选疫苗者接种了疫苗。


研究人员认为,达到消除乙型肝炎的目标需要多方面的方法来增加艾滋病病毒感染者的接种率。应该特别关注提高在私人诊所接受护理的患者的疫苗接种情况,以及在没有得到艾滋病毒/艾滋病方案资助的设施中接种疫苗。

原始出处:
John Weiser, MD, MPH; Alejandro Perez, MPH; Heather Bradley, PhD;et al.Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012 . Annals of Internal Medicine (2017). 

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2003360, encodeId=dce820033608e, content=<a href='/topic/show?id=5012890397' target=_blank style='color:#2F92EE;'>#HIV患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8903, encryptionId=5012890397, topicName=HIV患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b505306, createdName=医生2394, createdTime=Thu Jul 26 19:05:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608374, encodeId=d4ad16083e4ef, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Dec 28 05:05:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272688, encodeId=044c2e268860, content=预防接种.对防治传染病很重要., beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Dec 26 14:41:47 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2003360, encodeId=dce820033608e, content=<a href='/topic/show?id=5012890397' target=_blank style='color:#2F92EE;'>#HIV患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8903, encryptionId=5012890397, topicName=HIV患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b505306, createdName=医生2394, createdTime=Thu Jul 26 19:05:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608374, encodeId=d4ad16083e4ef, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Dec 28 05:05:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272688, encodeId=044c2e268860, content=预防接种.对防治传染病很重要., beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Dec 26 14:41:47 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2003360, encodeId=dce820033608e, content=<a href='/topic/show?id=5012890397' target=_blank style='color:#2F92EE;'>#HIV患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8903, encryptionId=5012890397, topicName=HIV患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b505306, createdName=医生2394, createdTime=Thu Jul 26 19:05:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608374, encodeId=d4ad16083e4ef, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Dec 28 05:05:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272688, encodeId=044c2e268860, content=预防接种.对防治传染病很重要., beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Dec 26 14:41:47 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
    2017-12-26 1e0f8808m18(暂无匿称)

    预防接种.对防治传染病很重要.

    0

相关威廉亚洲官网

超过三分之一的美国HIV患者没有接受乙肝疫苗接种

尽管有很高的感染风险,但美国超过三分之一的艾滋病患者没有接种乙肝疫苗。这些研究结果发表在《内科学年鉴》上。艾滋病毒感染者的乙肝病毒感染风险增加,建议接种疫苗。然而,艾滋病病毒感染者中与肝脏有关的死亡人数,其中以乙型肝炎为主,占与艾滋病无关的死亡人数的比例最大。2016年,世界卫生组织(WHO)决心在2030年前消除HBV感染作为公共卫生威胁。为了评估艾滋病毒患者乙肝疫苗接种的流行情况,并为世卫组织